Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
Pharma
Lilly pauses UK orders on its diabetes and obesity med Mounjaro
Lilly will resume taking U.K. Mounjaro requisitions Sept. 1 but has temporarily implemented a “month-end cut off for orders,” a spokesperson said.
Fraiser Kansteiner
Aug 28, 2025 11:08am
Mounjaro measures up to Trulicity in Eli Lilly cardio trial
Jul 31, 2025 8:12am
Experts hold line against mass compounding of GLP-1 obesity meds
Jun 27, 2025 10:36am
Compounders ordered to halt production of semaglutide knockoffs
Apr 25, 2025 10:25am
BMO says Lilly is pulling ahead of Novo in obesity market battle
Apr 17, 2025 4:30pm
Lilly files lawsuit against spa for selling repackaged Zepbound
Apr 7, 2025 5:00am